Literature DB >> 1263054

Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases.

A SanFilippo.   

Abstract

During a 1-yr period an increased incidence of hypertrophic PS was noted in a closed referral population. These patients demonstrated a temporal relationship between the ingestion of EE and the development of PS. A sequence of events from pylorospasm to pyloric tumors was suggested from the data.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1263054     DOI： 10.1016/0022-3468(76)90283-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN： 0022-3468            Impact factor:   2.545


  10 in total

1.  Hypertrophic pyloric stenosis caused by erythromycin.

Authors:  J Hoey
Journal:  CMAJ       Date:  2000-04-18       Impact factor: 8.262

Review 2.  Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis?

Authors:  Nitin Maheshwai
Journal:  Arch Dis Child       Date:  2007-03       Impact factor: 3.791

3.  Genome-wide high-density SNP-based linkage analysis of infantile hypertrophic pyloric stenosis identifies loci on chromosomes 11q14-q22 and Xq23.

Authors:  Kate V Everett; Barry A Chioza; Christina Georgoula; Ashley Reece; Francesca Capon; Keith A Parker; Cathy Cord-Udy; Paul McKeigue; Sally Mitton; Agostino Pierro; Prem Puri; Hannah M Mitchison; Eddie M K Chung; R Mark Gardiner
Journal:  Am J Hum Genet       Date:  2008-02-28       Impact factor: 11.025

Review 4.  The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?

Authors:  Manfred Hauben; Guy W Amsden
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.

Authors:  Mohammed Abdellatif; Sherief Ghozy; Mohamed Gomaa Kamel; Sameh Samir Elawady; Mohamed Mohy Eldeen Ghorab; Andrew Wassef Attia; Truong Thi Le Huyen; Diep Trong Vien Duy; Kenji Hirayama; Nguyen Tien Huy
Journal:  Eur J Pediatr       Date:  2018-11-23       Impact factor: 3.183

Review 6.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 7.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

8.  The ins and outs of pyloromyotomy: what we have learned in 35 years.

Authors:  Sigmund H Ein; Peter T Masiakos; Arlene Ein
Journal:  Pediatr Surg Int       Date:  2014-03-14       Impact factor: 1.827

Review 9.  Learning Lessons from Adverse Drug Reactions in Children.

Authors:  Helen M Sammons; Imti Choonara
Journal:  Children (Basel)       Date:  2016-01-08

10.  Safety of azithromycin in pediatrics: a systematic review and meta-analysis.

Authors:  Linan Zeng; Peipei Xu; Imti Choonara; Zhenyan Bo; Xiangchen Pan; Wenyan Li; Xiaofeng Ni; Tao Xiong; Can Chen; Leshan Huang; Shamim Ahmad Qazi; Dezhi Mu; Lingli Zhang
Journal:  Eur J Clin Pharmacol       Date:  2020-07-17       Impact factor: 2.953
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.